AzTrials
AzTrials

AnesthesiaPhase 4NCT05777135

Ringer Lactate Preloading on Induction Dose Requirement of Propofol

A Phase 4 study testing Ringer Lactate prior to surgery and Propofol in people with Anesthesia and Ringer's Lactate, run by National Medical College Birgunj at 1 site in Nepal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To compare the effect (heart rate and mean arterial pressure) of Ringer Lactate preloading and without preloading on induction dose requirement of Propofol. The Propofol requirement for induction dose with respect to loss of eyelash reflex in Ringer Lactate preloaded versus control group. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Anesthesia, Ringer's Lactate
What is being tested?
Ringer Lactate prior to surgery and Propofol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteNepal
Study dates
1 Apr 2023to 30 Jun 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients scheduled for elective surgeries
  • American Society of Anaesthesiologists (ASA) class I patients
  • Age between 18-45 years
  • Any surgery under general anaesthesia requiring endotracheal intubation
  • Body mass index (BMI) -18.5 - 24.9
  • Those providing written consent

Who cannot join

  • Emergency surgery
  • Patients with multiple injuries, pregnancy
  • Airway Mallampati grade II, III and IV
  • Allergy to Ringer Lactate and Propofol.

Trial locations and contacts

1 site in 1 country.

Dr Arushi Jaiswal contact

+9779841675096

arushij.dr16@gmail.com

Nepal1 site, 1 recruiting
  • National Medical College Teaching Hospital

    Birgunj, Madhesh, 44300

    Dr Arushi Jaiswal, +9779841675096, arushij.dr16@gmail.com

    Recruiting

Other trials in Nepal

About this study

Official title: Effect of Ringer Lactate Preloading on Induction Dose Requirement of Propofol and Its Haemodynamic Stability at a Tertiary Center

  • To compare the effect (heart rate and mean arterial pressure) of Ringer Lactate preloading and without preloading on induction dose requirement of Propofol.
  • The Propofol requirement for induction dose with respect to loss of eyelash reflex in Ringer Lactate preloaded versus control group.
Read the detailed description
  1. From the operation list, patients that meet the Inclusion criteria will be selected. (n=60)
  2. Patients will be allocated into two participant groups. Group I and Group II respectively using Simple random sampling technique by Ballot method. Ballot method is to keep the list of patients that meet the inclusion criteria in two ballot box mentioning name and groups and do the lottery based selection for both groups and Patient code will be given.
  3. Group I (n = 30) Preloading with Ringer Lactate 30 ml/kg over 30 mins prior to surgery will be done and Propofol dose (2mg / kg ) requirement for induction of anaesthesia will be noted. Group II (n = 30) No Preloading will be done and Propofol dose (2mg / kg) requirement for induction of anaesthesia will be noted.
  4. Then, investigators will visualize for loss of eyelash reflex in both groups.
  5. The hemodynamic response (heart rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure) to intubation between the two participant groups will be noted. The total Propofol requirement for induction in Ringer Lactate preloaded versus control group will be recorded.
  6. Drug administration and parameters recording will be done by the anaesthesiologist / under supervision
Being tested
Ringer Lactate prior to surgery and Propofol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ringer Lactate prior to surgery and PropofolDrug

    Also called Ringer Lactate group

    Ringer Lactate prior to surgery and Propofol dose requirement for induction of anaesthesia will be noted

Study groups in NCT05777135
Study groupRoleWhat they receive
Group I (Preloading with Ringer Lactate)ExperimentalPreloading with Ringer lactate 30ml/kg over 30 minutes prior to surgery and Propofol dose requirement for induction of anaesthesia will be noted
Receives: Drug: Ringer Lactate prior to surgery and Propofol
Group II (No preloading)No interventionNo preloading will be done and Propofol dose requirement for induction of anaesthesia will be noted

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Propofol dose Required (mg)

    Propofol dose (mg) with aspect to weight (kg)

    Measured: Standard dosing in Operation

  2. Total Propofol dose given (mg)

    Propofol dose (mg)

    Measured: Visualization of loss of eyelash reflex

  3. Loss of eyelash reflex (seconds)

    Visualization of loss of eyelash reflex (seconds)

    Measured: Propofol given till loss of eyelash reflex

Secondary outcomes (29)
  1. Units of Measure (e.g., weight and height)

    Weight in kilograms, height in meters ( weight and height will be combined to report BMI in kg/m²).

    Measured: Preanaesthetic checkup, Day 1

  2. Heart rate (beats / minute): After IV Propofol

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: Immediately After IV Propofol

  3. Heart rate (beats / minute): Baseline before IV fluid infusion

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: Base line Before IV fluid infusion

  4. Heart rate (beats / minute): At intubation (0 minute)

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: At intubation (0 minute)

  5. Heart rate (beats / minute): Post intubation (1 minute)

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: Post intubation (1 minute)

  6. Heart rate (beats / minute): Post intubation (3 minute)

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: Post intubation (3 minute)

  7. Heart rate (beats / minute): Post intubation (5 minute)

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: Post intubation (5 minute)

  8. Heart rate (beats / minute): Post intubation (10 minute)

    Heart rate (beats / minute) will be measured with pulse oxymeter

    Measured: Post intubation (10 minute)

  9. Systolic blood pressure (mm Hg): Baseline before IV fluid infusion

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Baseline before IV fluid infusion

  10. Systolic blood pressure (mm Hg): After IV Propofol

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Immediately After IV Propofol

  11. Systolic blood pressure (mm Hg): At intubation (0 minute)

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: At intubation (0 minute)

  12. Systolic blood pressure (mm Hg): Post intubation (1 minute)

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (1 minute)

  13. Systolic blood pressure (mm Hg): Post intubation (3 minute)

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (3 minute)

  14. Systolic blood pressure (mm Hg): Post intubation (5 minute)

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (5 minute)

  15. Systolic blood pressure (mm Hg): Post intubation (10 minute)

    Systolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (10 minute)

  16. Diastolic blood pressure (mm Hg): Baseline before IV fluid infusion

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Baseline before IV fluid infusion

  17. Diastolic blood pressure (mm Hg): After IV Propofol

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Immediately After IV Propofol

  18. Diastolic blood pressure (mm Hg): At intubation (0 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: At intubation (0 minute)

  19. Diastolic blood pressure (mm Hg): Post intubation (1 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (1 minute)

  20. Diastolic blood pressure (mm Hg): Post intubation (3 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (3 minute)

  21. Diastolic blood pressure (mm Hg): Post intubation (5 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (5 minute)

  22. Diastolic blood pressure (mm Hg): Post intubation (10 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (10 minute)

  23. Mean arterial pressure (mm Hg): After IV Propofol

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Immediately After IV Propofol

  24. Mean arterial pressure (mm Hg): Baseline before IV fluid infusion

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Baseline before IV fluid infusion

  25. Mean arterial pressure (mm Hg): At intubation (0 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: At intubation (0 minute)

  26. Mean arterial pressure (mm Hg): Post intubation (1 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (1 minute)

  27. Mean arterial pressure (mm Hg): Post intubation (3 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (3 minute)

  28. Mean arterial pressure (mm Hg): Post intubation (5 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (5 minute)

  29. Mean arterial pressure (mm Hg): Post intubation (10 minute)

    Diastolic blood pressure (mm Hg) will be recorded on vital monitor

    Measured: Post intubation (10 minute)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2023
  2. Study start1 Apr 2023
  3. Primary completion31 Mar 2024 (estimated)
  4. Study completion30 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05777135
Sponsor's protocol ID
519 - 2022
Status last verified
Apr 2023
First submitted
1 Feb 2023
Last updated
5 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology. 1994 Oct;81(4):1005-43. No abstract available.

    PubMed 7943815
  • Hug CC Jr, McLeskey CH, Nahrwold ML, Roizen MF, Stanley TH, Thisted RA, Walawander CA, White PF, Apfelbaum JL, Grasela TH, et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg. 1993 Oct;77(4 Suppl):S21-9.

    PubMed 8214693
  • Van Aken H, Meinshausen E, Prien T, Brussel T, Heinecke A, Lawin P. The influence of fentanyl and tracheal intubation on the hemodynamic effects of anesthesia induction with propofol/N2O in humans. Anesthesiology. 1988 Jan;68(1):157-63. doi: 10.1097/00000542-198801000-00031. No abstract available.

    PubMed 3257362
  • Briggs LP, Dundee JW, Bahar M, Clarke RS. Comparison of the effect of diisopropyl phenol (ICI 35, 868) and thiopentone on response to somatic pain. Br J Anaesth. 1982 Mar;54(3):307-11. doi: 10.1093/bja/54.3.307.

    PubMed 6978144
  • McCollum JS, Milligan KR, Dundee JW. The antiemetic action of propofol. Anaesthesia. 1988 Mar;43(3):239-40. doi: 10.1111/j.1365-2044.1988.tb05551.x.

    PubMed 3259081
  • Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999 May;88(5):999-1003. doi: 10.1097/00000539-199905000-00006.

    PubMed 10320158

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Ringer Lactate prior to surgery and Propofol in people with Anesthesia and Ringer's Lactate, run by National Medical College Birgunj at 1 site in Nepal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Nepal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dr Arushi Jaiswal (+9779841675096, arushij.dr16@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Propofol dose Required (mg) (time frame: Standard dosing in Operation). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05777135, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in